Vimarsana
Biggest News Aggregation in the World

Executive Albert Bourla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Executive Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Executive Albert Bourla Today - Breaking & Trending Today

Pfizer increases dividend by one penny to 42 cents a share - Vimarsana News

Pfizer increases dividend by one penny to 42 cents a share

Pfizer Inc. said late Thursday that its board of directors declared an increase in the company’s quarterly dividend to 42 cents a share, from 41 cents a...

Pfizer's stock down 7% as 2024 guidance for profit and revenue lags consensus - Vimarsana News

Pfizer's stock down 7% as 2024 guidance for profit and revenue lags consensus

Pfizer Inc.’s stock slid 7% premarket Wednesday, after the drug company set guidance for 2024 that lagged consensus. Pfizer, which is hosting an investor day...

Pfizer shares tumble on disappointing 2024 profit outlook - Vimarsana News

Pfizer shares tumble on disappointing 2024 profit outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic. The company, which reported more than $100 billion in revenue in 2022 due to the lift from Covid-19 vaccine and therapeutic sales, sees 2024 revenues of between $58.5 billion and $61.5 billion, according to its presentation.

Source: yahoo.com
Pfizer Shares Tumble On Disappointing 2024 Profit Outlook - Vimarsana News

Pfizer Shares Tumble On Disappointing 2024 Profit Outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

Pfizer shares tumble on disappointing 2024 profit outlook - Vimarsana News

Pfizer shares tumble on disappointing 2024 profit outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.